spacer
home > epc > Spring 2018
PUBLICATIONS

European Pharmaceutical Contractor

epc
Spring 2018

   
Text
PDF
bullet
Clinical Laboratories & Logistics
Q&A: Clinical Finances

Money Matters

The many financial aspects that must be considered within a clinical trial and the role that a CRO plays in the process are explored by Greenphire’s Dave Espenshade.
 
view
download pdf
Patient Centricity

A Winning Formula

To fully realise commercialisation and drug development, patient centricity is an important factor to consider. Justin Schroeder at PCI Pharma Services demonstrates how this can help a patient-focused approach excel.
 
view
download pdf
Early Phase Development

Early Beginnings

Dr Torkel Gren at Recipharm Pharmaceutical Development and Anders Millerhovf at CTC Clinical Trial Consultants examine an integrated approach to early phase trials that will ensure new drugs are effectively and securely produced.
 
view
download pdf
Content Management

Data Diligence

Pharmaceutical companies need to gather data from busy healthcare professionals, and they should pay attention to how to do this and the ways in which it can be used to develop supply and logistics, says Kieran Bourke at MAXX Design.
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August and November

News and Press Releases

Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation Pvt. Ltd. for cGMP Quaternary Ammonium Compounds for pharmaceutical and medical device applications

Novo Nordisk Pharmatech A/S has entered into an agreement with Signet Chemical Corporation Pvt. Ltd. for the distribution of their pharmaceutical range of quaternary ammonium compounds (FEF® Quats) to the healthcare industry in India, Bangladesh and Sri Lanka.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>

Industry Events

Clinical Trial Supply Southeast 2018

2-3 October 2018, Cary, North Carolina

Clinical Trial Supply Southeast will return to Cary, North Carolina for fall 2018. Part of our global series of events, this show will attract the leading biotech and pharma companies from the Southeast region, the event will focus on how companies can adapt their supply chains to fit into the highly regulated world.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement